Value of allohaemagglutinins in the diagnosis of a polysaccharide antibody deficiency

Polysaccharide antibody deficiency is characterized by a poor or absent antibody response after vaccination with an unconjugated pneumococcal polysaccharide vaccine. Allohemagglutinins (AHA) are antibodies to A or B polysaccharide antigens on the red blood cells and are often used as an additional or alternative measure to assess the polysaccharide antibody response. However, few studies have been conducted to establish the clinical significance of AHA. To investigate the value of AHA to diagnose a polysaccharide antibody deficiency, pneumococcal polysaccharide antibody titers and AHA were retrospectively studied in 180 subjects in whom both tests had been performed. Receiver Operating Characteristic curves for AHA versus the pneumococcal vaccine response as a marker for the anti-polysaccharide immune response revealed an area under the curve between 0.5 and 0.573. Sensitivity and specificity of AHA to detect a polysaccharide antibody deficiency, as diagnosed by vaccination response, were low (calculated for cut-off 1/4 - 1/32). In subjects with only low pneumococcal antibody response the prevalence of bronchiectasis was significantly higher than in subjects with only low AHA (45.5% and 1.3% respectively) or normal pneumococcal antibody response and AHA (2.4%). A logistic regression model showed that low pneumococcal antibody response but not AHA was associated with bronchiectasis (Odds ratio 46.2). The results of this study do not support routine use of AHA to assess the polysaccharide antibody response in patients with suspected immunodeficiency but more studies are warranted to further clarify the subject.status: publishe